{"matchedTerms": [], "ambiguousTerms": [{"searchTerm": "3767", "geneName": "KCNJ11", "geneLongName": "POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY J MEMBER 11", "entrezId": 3767, "geneCategories": [{"id": "b2e1d6814868498b8865b055d8972250", "name": "ION CHANNEL"}, {"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}], "interactions": [{"interactionId": "a6b00b7b-a237-40d1-9962-03e8496ce0ce", "interactionTypes": ["inhibitor"], "drugName": "THIAMYLAL", "drugConceptId": "chembl:CHEMBL440", "sources": ["TdgClinicalTrial", "TEND"], "pmids": [10754636, 15852621, 14739809], "score": 2.76}, {"interactionId": "1a768587-4fe8-4bf4-9116-c7f38ae7df6d", "interactionTypes": ["blocker", "inhibitor"], "drugName": "GLYBURIDE", "drugConceptId": "chembl:CHEMBL472", "sources": ["TdgClinicalTrial", "ChemblInteractions", "TEND", "PharmGKB"], "pmids": [24442125, 16595597, 11318841, 9593694, 22385882, 25115353], "score": 1.47}, {"interactionId": "8a31eaa9-03d7-4a6c-9d69-acf89a97a935", "interactionTypes": ["blocker"], "drugName": "ACETOHEXAMIDE", "drugConceptId": "chembl:CHEMBL1589", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.74}, {"interactionId": "e161e3b0-11a6-4959-b839-59535d915d08", "interactionTypes": ["inducer"], "drugName": "DIAZOXIDE", "drugConceptId": "chembl:CHEMBL181", "sources": ["ChemblInteractions", "PharmGKB"], "pmids": [16885550, 10581306, 11808879, 12770942, 10604939, 10518593, 12199344, 15807877], "score": 1.7}, {"interactionId": "83615241-641f-4373-b519-adc8d29e7c60", "interactionTypes": ["blocker"], "drugName": "TOLAZAMIDE", "drugConceptId": "chembl:CHEMBL817", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.32}, {"interactionId": "0a8d3aee-1325-482e-b86c-b5d8c09b2408", "interactionTypes": ["blocker"], "drugName": "TOLBUTAMIDE SODIUM, STERILE", "drugConceptId": "chembl:CHEMBL1200874", "sources": ["ChemblInteractions"], "pmids": [], "score": 1.1}, {"interactionId": "ea34401d-4cd7-4a9e-987c-d0d4409e186e", "interactionTypes": [], "drugName": "SARAKALIM", "drugConceptId": "chembl:CHEMBL2104449", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.55}, {"interactionId": "d555baa8-d967-48d9-af40-09a364c6662f", "interactionTypes": [], "drugName": "FLECAINIDE", "drugConceptId": "chembl:CHEMBL652", "sources": ["NCI"], "pmids": [11429398], "score": 0.88}, {"interactionId": "c6177e9c-3f54-4d37-8570-7d3835a3948e", "interactionTypes": ["blocker", "inhibitor"], "drugName": "TOLBUTAMIDE", "drugConceptId": "chembl:CHEMBL782", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.32}, {"interactionId": "31185105-5532-4aa6-9981-084a9c09b75f", "interactionTypes": [], "drugName": "STREPTOZOCIN", "drugConceptId": "chembl:CHEMBL1651906", "sources": ["NCI"], "pmids": [11798815], "score": 0.1}, {"interactionId": "4573bf75-fdf0-4993-8ab7-c81f97c2749e", "interactionTypes": ["inducer"], "drugName": "LEVOSIMENDAN", "drugConceptId": "chembl:CHEMBL2051955", "sources": ["TdgClinicalTrial"], "pmids": [17452812], "score": 2.21}, {"interactionId": "c66efc94-ebb9-46a2-91e3-ec706512dd8e", "interactionTypes": ["blocker", "inhibitor"], "drugName": "GLIMEPIRIDE", "drugConceptId": "chembl:CHEMBL1481", "sources": ["TdgClinicalTrial", "ChemblInteractions", "NCI", "TEND", "PharmGKB"], "pmids": [12086984, 24442125, 12703060, 16595597, 11318841, 22385882, 25115353, 11325810], "score": 3.59}, {"interactionId": "ee6fda53-0ab9-4992-bbb6-4f3e5c039fda", "interactionTypes": [], "drugName": "BERBERINE CHLORIDE", "drugConceptId": "chembl:CHEMBL12089", "sources": ["DTC"], "pmids": [16359864], "score": 0.55}, {"interactionId": "f5ff7901-0b0d-4a34-8a75-ad23e3e0243f", "interactionTypes": [], "drugName": "BERBERRUBINE", "drugConceptId": "chembl:CHEMBL203135", "sources": ["DTC"], "pmids": [16359864], "score": 1.1}, {"interactionId": "55459219-4512-4511-ae3d-6e18364fbbfd", "interactionTypes": ["blocker"], "drugName": "CHLORPROPAMIDE", "drugConceptId": "chembl:CHEMBL498", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.2}, {"interactionId": "63150d30-22ae-4c81-9942-1802305354f3", "interactionTypes": ["blocker"], "drugName": "GLIPIZIDE", "drugConceptId": "chembl:CHEMBL1073", "sources": ["ChemblInteractions", "PharmGKB"], "pmids": [24442125, 16595597, 11318841, 22385882, 25115353], "score": 2.21}, {"interactionId": "f5adc9ea-67bd-4d35-83cb-136ab37a35c3", "interactionTypes": [], "drugName": "NAMINIDIL", "drugConceptId": "chembl:CHEMBL2105160", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.55}, {"interactionId": "ba16729c-ade7-40b8-8983-58420df0ca13", "interactionTypes": [], "drugName": "GLICLAZIDE", "drugConceptId": "chembl:CHEMBL427216", "sources": ["PharmGKB"], "pmids": [24442125, 16595597, 11318841, 22385882, 25115353], "score": 2.21}, {"interactionId": "913849a2-5b75-444c-973c-b1dc1dee6623", "interactionTypes": [], "drugName": "MITIGLINIDE", "drugConceptId": "chembl:CHEMBL471498", "sources": ["TEND"], "pmids": [], "score": 0.74}, {"interactionId": "25dc9d6d-4255-4f2e-bb5f-ced60f896d24", "interactionTypes": ["blocker"], "drugName": "NATEGLINIDE", "drugConceptId": "chembl:CHEMBL783", "sources": ["ChemblInteractions", "TEND"], "pmids": [], "score": 0.44}, {"interactionId": "8b4a2c35-87d1-4261-a879-fc26294b0c66", "interactionTypes": ["activator"], "drugName": "MINOXIDIL", "drugConceptId": "chembl:CHEMBL802", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.22}, {"interactionId": "9cfd2818-d364-4338-aac9-d76436dfe9c0", "interactionTypes": [], "drugName": "PHENTOLAMINE", "drugConceptId": "chembl:CHEMBL597", "sources": ["NCI"], "pmids": [9326676], "score": 0.49}, {"interactionId": "a5b176cb-ef8c-4e23-8177-48e126c535f8", "interactionTypes": [], "drugName": "EPIGALOCATECHIN GALLATE", "drugConceptId": "chembl:CHEMBL297453", "sources": ["NCI"], "pmids": [17656102], "score": 0.17}, {"interactionId": "b0ed4a04-da6e-4845-a109-db639c8aea2c", "interactionTypes": [], "drugName": "PINACIDIL", "drugConceptId": "chembl:CHEMBL1200338", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.55}, {"interactionId": "0c9c059f-8a39-4168-b8d7-99125d0a0394", "interactionTypes": [], "drugName": "GLIQUIDONE", "drugConceptId": "chembl:CHEMBL383634", "sources": ["DTC", "PharmGKB"], "pmids": [24442125, 16359864, 16595597, 11318841, 22385882, 25115353], "score": 2.52}, {"interactionId": "306eae43-28df-42d5-bc06-8707a2174b37", "interactionTypes": ["blocker"], "drugName": "REPAGLINIDE", "drugConceptId": "chembl:CHEMBL1272", "sources": ["ChemblInteractions", "TEND", "PharmGKB"], "pmids": [20054294], "score": 0.59}, {"interactionId": "1281daef-bc16-46f6-b602-bbe631b3b604", "interactionTypes": [], "drugName": "TACROLIMUS", "drugConceptId": "chembl:CHEMBL269732", "sources": ["PharmGKB"], "pmids": [22264780], "score": 0.13}, {"interactionId": "e3672e88-27e0-4a51-a641-dcb4216e0ed4", "interactionTypes": [], "drugName": "METFORMIN", "drugConceptId": "chembl:CHEMBL1431", "sources": ["PharmGKB"], "pmids": [16595597], "score": 0.12}]}, {"searchTerm": "3767", "geneName": "FLT4", "geneLongName": "FMS RELATED TYROSINE KINASE 4", "entrezId": 2324, "geneCategories": [{"id": "4c14ec3171544bd2b18b2f1a45e6c8f2", "name": "KINASE"}, {"id": "6c528ef943614261afc5e4f52a3c60ee", "name": "TYROSINE KINASE"}, {"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}, {"id": "0d157beb-fd17-404d-8755-3a81aa5ed704", "name": "CLINICALLY ACTIONABLE"}], "interactions": [{"interactionId": "878a6a07-3029-4670-8d7a-3407d4ecc95a", "interactionTypes": [], "drugName": "GW843682X", "drugConceptId": "chembl:CHEMBL514499", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "ff2ff02e-0d92-4e8f-ab5f-13877426e2fb", "interactionTypes": ["inhibitor"], "drugName": "VANDETANIB", "drugConceptId": "chembl:CHEMBL24828", "sources": ["TALC", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions", "MyCancerGenomeClinicalTrial"], "pmids": [], "score": 0.07}, {"interactionId": "a62ba313-0984-4124-9355-f87f76c951ac", "interactionTypes": ["inhibitor"], "drugName": "FRUQUINTINIB", "drugConceptId": "chembl:CHEMBL3545339", "sources": ["TdgClinicalTrial", "ChemblInteractions", "TTD"], "pmids": [], "score": 0.74}, {"interactionId": "9e3d334a-ce92-47b9-8902-95a0fb924b93", "interactionTypes": ["inhibitor"], "drugName": "SURUFATINIB", "drugConceptId": "chembl:CHEMBL4297190", "sources": ["ChemblInteractions", "TTD"], "pmids": [], "score": 0.3}, {"interactionId": "1239442e-0862-4826-b4f9-e9c92e6aedab", "interactionTypes": [], "drugName": "KENPAULLONE", "drugConceptId": "chembl:CHEMBL296586", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "66626fbf-6964-4505-88bc-6dc3d0b99ada", "interactionTypes": [], "drugName": "OSI-632", "drugConceptId": "chembl:CHEMBL253969", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "a443dfca-9055-45c3-86fa-27216848d717", "interactionTypes": [], "drugName": "SP-600125", "drugConceptId": "chembl:CHEMBL1725279", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "19e2b819-d84e-4de7-bb5e-ba19b7d5d215", "interactionTypes": ["inhibitor"], "drugName": "CEDIRANIB", "drugConceptId": "chembl:CHEMBL491473", "sources": ["TALC", "DTC", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.08}, {"interactionId": "649e9b8e-851c-46b1-b3eb-e1ad9c291988", "interactionTypes": [], "drugName": "MUPARFOSTAT", "drugConceptId": "chembl:CHEMBL4297163", "sources": ["TdgClinicalTrial", "TTD"], "pmids": [], "score": 0.15}, {"interactionId": "dc159683-d218-411b-bbc8-8d213c4d85a1", "interactionTypes": [], "drugName": "CHLORPYRAMIN HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL550011", "sources": ["DTC"], "pmids": [19610651], "score": 0.74}, {"interactionId": "ed727d0d-9a7e-4cbf-a3cb-f7576a310a51", "interactionTypes": ["inhibitor"], "drugName": "AXITINIB", "drugConceptId": "chembl:CHEMBL1289926", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions", "CancerCommons", "MyCancerGenomeClinicalTrial"], "pmids": [18541897], "score": 0.43}, {"interactionId": "df7531b9-28d5-414a-b8b3-ad088d53b60e", "interactionTypes": ["inhibitor"], "drugName": "CEP-5214", "drugConceptId": "chembl:CHEMBL150894", "sources": ["DTC", "ChemblInteractions"], "pmids": [14640546], "score": 0.74}, {"interactionId": "8328fe75-9aa4-4e37-987b-43800a176a38", "interactionTypes": ["inhibitor"], "drugName": "ORANTINIB", "drugConceptId": "chembl:CHEMBL274654", "sources": ["MyCancerGenome"], "pmids": [], "score": 0.08}, {"interactionId": "0306dbc8-fc90-497e-8d2b-6bb4edb1b8e2", "interactionTypes": ["inhibitor"], "drugName": "4SC-203", "drugConceptId": "chembl:CHEMBL3545358", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.19}, {"interactionId": "0b5a19fe-7d9b-49c4-9d46-80ea3ed9b85e", "interactionTypes": ["inhibitor"], "drugName": "MOTESANIB", "drugConceptId": "chembl:CHEMBL572881", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.37}, {"interactionId": "2890307c-c9ca-450c-a291-46b6dcbe5344", "interactionTypes": ["inhibitor"], "drugName": "FAMITINIB", "drugConceptId": "chembl:CHEMBL3545026", "sources": ["ChemblInteractions", "TTD"], "pmids": [], "score": 0.21}, {"interactionId": "d1e966cc-17b3-472d-86e6-6aee8ed60715", "interactionTypes": ["inhibitor"], "drugName": "BMS-690514", "drugConceptId": "chembl:CHEMBL3545396", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.11}, {"interactionId": "a5e89dc0-bd97-4015-a522-cefee74bb6d8", "interactionTypes": ["inhibitor"], "drugName": "ILORASERTIB", "drugConceptId": "chembl:CHEMBL1980297", "sources": ["DTC", "ChemblInteractions"], "pmids": [], "score": 0.01}, {"interactionId": "0d19132f-a2ea-4c48-9bfd-88591ab884b7", "interactionTypes": ["inhibitor"], "drugName": "RG-1530", "drugConceptId": "chembl:CHEMBL1980391", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.01}, {"interactionId": "7a1eaa6f-8f6b-4657-a112-858e63de3024", "interactionTypes": ["inhibitor"], "drugName": "ENMD-2076", "drugConceptId": "chembl:CHEMBL482968", "sources": ["MyCancerGenome", "TdgClinicalTrial"], "pmids": [], "score": 0.06}, {"interactionId": "b0d8dc7c-8888-4fff-beba-59128ad014ab", "interactionTypes": [], "drugName": "PF-00562271", "drugConceptId": "chembl:CHEMBL1084546", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "80f91b9a-595d-40bf-be0e-53d3b6338261", "interactionTypes": ["inhibitor"], "drugName": "XL-999", "drugConceptId": "chembl:CHEMBL3545285", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.07}, {"interactionId": "ae6b1bfc-e2a9-4b0e-b2c7-d7e135f9a7a5", "interactionTypes": ["inhibitor"], "drugName": "TIVOZANIB", "drugConceptId": "chembl:CHEMBL1289494", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions", "TTD"], "pmids": [], "score": 0.74}, {"interactionId": "d8833e4d-5e76-477a-9b16-f32963eac4da", "interactionTypes": ["inhibitor"], "drugName": "GLESATINIB", "drugConceptId": "chembl:CHEMBL3989914", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial"], "pmids": [], "score": 0.28}, {"interactionId": "e1ccbbcb-8946-49b7-bde2-0b0a9063d473", "interactionTypes": ["inhibitor"], "drugName": "CEP-11981", "drugConceptId": "chembl:CHEMBL2010872", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.07}, {"interactionId": "344bc37d-64b1-4bd0-a12b-0b1ad835d963", "interactionTypes": [], "drugName": "MLN-8054", "drugConceptId": "chembl:CHEMBL259084", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "0e727c88-384a-4850-b664-a761e6436007", "interactionTypes": ["inhibitor"], "drugName": "PAZOPANIB HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL1201733", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.07}, {"interactionId": "83531262-f588-4d46-a95e-b499c0f3033c", "interactionTypes": [], "drugName": "DORAMAPIMOD", "drugConceptId": "chembl:CHEMBL103667", "sources": ["DTC"], "pmids": [], "score": 0.04}, {"interactionId": "c6ea8aa8-327b-47d6-8936-0a10a1070b10", "interactionTypes": ["inhibitor"], "drugName": "TAK-593", "drugConceptId": "chembl:CHEMBL2180604", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.15}, {"interactionId": "528fade9-5b8e-4ce1-ab42-db0c236f2acb", "interactionTypes": [], "drugName": "SB-220025", "drugConceptId": "chembl:CHEMBL274064", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "272e345f-f8a0-414f-8cb0-5832b82d299f", "interactionTypes": [], "drugName": "GO-6976", "drugConceptId": "chembl:CHEMBL302449", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "19bc2aa7-75d0-4e15-b560-461268901d51", "interactionTypes": [], "drugName": "CENISERTIB", "drugConceptId": "chembl:CHEMBL1967878", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "63ba7580-2cf8-4630-9b5d-65ed95faf499", "interactionTypes": ["inhibitor"], "drugName": "SUNITINIB MALATE", "drugConceptId": "chembl:CHEMBL1567", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.08}, {"interactionId": "b2575ba3-2e1b-40d4-969a-5199f895647a", "interactionTypes": ["inhibitor"], "drugName": "BRIVANIB", "drugConceptId": "chembl:CHEMBL377300", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.07}, {"interactionId": "b1b29875-e975-4bd3-8aa6-84cb43cf16e0", "interactionTypes": [], "drugName": "GW441756X", "drugConceptId": "chembl:CHEMBL1516890", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "198cec18-8ca7-48f3-84ce-7eac3bbab783", "interactionTypes": ["inhibitor"], "drugName": "BRIVANIB ALANINATE", "drugConceptId": "chembl:CHEMBL270995", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.11}, {"interactionId": "d0b8a1a2-26e9-4fa4-b87a-463a7246d7a3", "interactionTypes": ["inhibitor"], "drugName": "VATALANIB", "drugConceptId": "chembl:CHEMBL101253", "sources": ["DTC", "MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions", "TTD"], "pmids": [17584317], "score": 0.34}, {"interactionId": "5d5f242e-0731-45e6-82bd-ce73788301bf", "interactionTypes": ["inhibitor"], "drugName": "CHIAURANIB", "drugConceptId": "chembl:CHEMBL3545428", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.19}, {"interactionId": "1ab9fdb2-6ed7-4706-bfda-138523d172e4", "interactionTypes": [], "drugName": "IMC-3C5", "drugConceptId": "chembl:CHEMBL2109602", "sources": ["TdgClinicalTrial", "TTD"], "pmids": [22515444], "score": 2.23}, {"interactionId": "492dc04b-b6b3-4087-8b15-f14e9a5c2228", "interactionTypes": ["inhibitor"], "drugName": "CP-459632", "drugConceptId": "chembl:CHEMBL3545300", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.09}, {"interactionId": "2cfc910f-d470-4b5e-a443-9b40abd76d8c", "interactionTypes": [], "drugName": "SB-203580", "drugConceptId": "chembl:CHEMBL10", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "dc31d111-3833-49f5-b339-671ceea8761b", "interactionTypes": ["inhibitor"], "drugName": "TELATINIB", "drugConceptId": "chembl:CHEMBL2079588", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.5}, {"interactionId": "400e6d87-cfaa-47d3-b697-880dcd9a7eee", "interactionTypes": [], "drugName": "GEFITINIB", "drugConceptId": "chembl:CHEMBL939", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "997f65e0-5bba-4dcb-b3f6-bc0f544b45df", "interactionTypes": ["inhibitor"], "drugName": "SEMAXANIB", "drugConceptId": "chembl:CHEMBL276711", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.05}, {"interactionId": "24801a0e-b40e-4d2a-99be-e721f35a4bca", "interactionTypes": [], "drugName": "TOZASERTIB", "drugConceptId": "chembl:CHEMBL572878", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "2d2bdda0-066b-494b-b68c-8be533572f86", "interactionTypes": ["inhibitor"], "drugName": "OSI-930", "drugConceptId": "chembl:CHEMBL1614710", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.15}, {"interactionId": "df8d75ce-e090-46ac-8d3b-8894bca4fff6", "interactionTypes": ["inhibitor"], "drugName": "XL-820", "drugConceptId": "chembl:CHEMBL3545402", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.12}, {"interactionId": "03ac2150-925d-4b9f-9a51-aa9ca802557e", "interactionTypes": ["inhibitor"], "drugName": "X-82", "drugConceptId": "chembl:CHEMBL3545401", "sources": ["MyCancerGenome", "ChemblInteractions"], "pmids": [], "score": 0.3}, {"interactionId": "4ad8dc13-5176-4a53-bc0b-d54e26579a61", "interactionTypes": ["inhibitor"], "drugName": "NINTEDANIB", "drugConceptId": "chembl:CHEMBL502835", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ClearityFoundationClinicalTrial"], "pmids": [18559524, 31016670], "score": 0.21}, {"interactionId": "75336b09-636d-4088-909e-43bb38432d56", "interactionTypes": ["inhibitor"], "drugName": "LUCITANIB", "drugConceptId": "chembl:CHEMBL2220486", "sources": ["ChemblInteractions", "MyCancerGenomeClinicalTrial"], "pmids": [], "score": 0.25}, {"interactionId": "125ba426-162c-4b0f-9636-b9caedccd4c0", "interactionTypes": [], "drugName": "TAE-684", "drugConceptId": "chembl:CHEMBL509032", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "6584e832-497e-4a0e-a230-f49c4daf50de", "interactionTypes": [], "drugName": "ERLOTINIB", "drugConceptId": "chembl:CHEMBL553", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "98991337-2681-4d31-854d-ee3c11f6c254", "interactionTypes": ["inhibitor"], "drugName": "RABEPRAZOLE SODIUM", "drugConceptId": "chembl:CHEMBL1200930", "sources": ["MyCancerGenome", "TTD"], "pmids": [], "score": 0.09}, {"interactionId": "05c1f1b9-cacd-49f3-9c97-a4ca3144b5d9", "interactionTypes": ["inhibitor"], "drugName": "FORETINIB", "drugConceptId": "chembl:CHEMBL1230609", "sources": ["MyCancerGenome", "ChemblInteractions"], "pmids": [], "score": 0.12}, {"interactionId": "61baaf84-24fd-4616-8d8d-193c306aef19", "interactionTypes": [], "drugName": "AZAKENPAULLONE", "drugConceptId": "chembl:CHEMBL336961", "sources": ["DTC"], "pmids": [], "score": 0.07}, {"interactionId": "830d95d7-5659-4d65-ba4f-a27973d60225", "interactionTypes": ["inhibitor"], "drugName": "SORAFENIB TOSYLATE", "drugConceptId": "chembl:CHEMBL1200485", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.05}, {"interactionId": "93736424-c20c-43c4-ae6d-d5b5e3c29081", "interactionTypes": [], "drugName": "ALSTERPAULLONE", "drugConceptId": "chembl:CHEMBL50894", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "2ecec56e-f747-4bb4-b403-1b6d6666e37d", "interactionTypes": ["inhibitor"], "drugName": "SU-014813", "drugConceptId": "chembl:CHEMBL1721885", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.11}, {"interactionId": "61038640-a734-4861-ad68-3712fc963daa", "interactionTypes": [], "drugName": "ENTRECTINIB", "drugConceptId": "chembl:CHEMBL1983268", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "50a0e44c-ae92-43ab-8db0-52edda8adb99", "interactionTypes": ["inhibitor"], "drugName": "LENVATINIB", "drugConceptId": "chembl:CHEMBL1289601", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial"], "pmids": [17943726], "score": 0.25}, {"interactionId": "78cafeed-69a2-4dae-8707-f17b7cce6ca0", "interactionTypes": [], "drugName": "TANDUTINIB", "drugConceptId": "chembl:CHEMBL124660", "sources": ["DTC"], "pmids": [], "score": 0.07}, {"interactionId": "7bb521e0-0761-447c-bb31-93b878318cfb", "interactionTypes": ["inhibitor"], "drugName": "L-21649", "drugConceptId": "chembl:CHEMBL3544927", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.25}, {"interactionId": "73b1e6c9-462b-4bff-a1d7-596a0cfb2ef1", "interactionTypes": [], "drugName": "SOTRASTAURIN", "drugConceptId": "chembl:CHEMBL565612", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "da29f5f1-6bab-4622-b266-6aa1d5a05997", "interactionTypes": [], "drugName": "GSK-269962A", "drugConceptId": "chembl:CHEMBL220241", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "97bb15d6-f195-443b-86f7-272ade66e53c", "interactionTypes": [], "drugName": "TAK-715", "drugConceptId": "chembl:CHEMBL363648", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "25e26ad7-5c45-42a0-96e8-a51055ea9f16", "interactionTypes": ["inhibitor"], "drugName": "CEP-7055", "drugConceptId": "chembl:CHEMBL346631", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.25}, {"interactionId": "8b042658-92fb-400b-9599-f3254c3aee73", "interactionTypes": ["inhibitor"], "drugName": "AG-13958", "drugConceptId": "chembl:CHEMBL3545335", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.25}, {"interactionId": "bd1aca5d-61d3-48b5-a3ca-b0eadd5013b3", "interactionTypes": ["inhibitor"], "drugName": "PAZOPANIB", "drugConceptId": "chembl:CHEMBL477772", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "CIViC", "MyCancerGenomeClinicalTrial"], "pmids": [27160228, 28377484, 17288876], "score": 0.15}, {"interactionId": "0027008a-111f-43a0-ab49-4d4b350e8ca1", "interactionTypes": ["inhibitor"], "drugName": "REGORAFENIB", "drugConceptId": "chembl:CHEMBL1946170", "sources": ["TALC", "MyCancerGenome", "ChemblInteractions", "MyCancerGenomeClinicalTrial"], "pmids": [], "score": 0.11}, {"interactionId": "6140d198-09ce-4292-965d-d8e7f15ec50c", "interactionTypes": ["inhibitor"], "drugName": "KRN-633", "drugConceptId": "chembl:CHEMBL406381", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.25}, {"interactionId": "94733913-5f35-4144-95e4-b7f614491871", "interactionTypes": ["inhibitor"], "drugName": "LENVATINIB MESYLATE", "drugConceptId": "chembl:CHEMBL2105704", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.25}, {"interactionId": "2eff0bad-086b-4e48-984d-4ad22aaada70", "interactionTypes": ["inhibitor"], "drugName": "TESEVATINIB", "drugConceptId": "chembl:CHEMBL3544983", "sources": ["MyCancerGenome", "TdgClinicalTrial"], "pmids": [], "score": 0.21}, {"interactionId": "0e23483f-72ee-4b63-89d5-063e1b3951ca", "interactionTypes": ["inhibitor"], "drugName": "MGCD-265", "drugConceptId": "chembl:CHEMBL254760", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.12}, {"interactionId": "814c4b76-fe50-466a-9f9d-77516de324e2", "interactionTypes": ["inhibitor"], "drugName": "SUNITINIB", "drugConceptId": "chembl:CHEMBL535", "sources": ["TALC", "TdgClinicalTrial", "TEND", "MyCancerGenomeClinicalTrial", "PharmGKB"], "pmids": [15688612, 17605814, 17296815, 22015057, 19248971, 17367763, 16685460], "score": 0.23}, {"interactionId": "5a3cc0d9-50a9-47c5-9afb-21c0513ddd2e", "interactionTypes": ["inhibitor"], "drugName": "MK-2461", "drugConceptId": "chembl:CHEMBL1822792", "sources": ["TTD"], "pmids": [], "score": 0.06}, {"interactionId": "bb168492-ac89-4c17-8970-c21f7717a9d8", "interactionTypes": ["antagonist", "inhibitor"], "drugName": "SORAFENIB", "drugConceptId": "chembl:CHEMBL1336", "sources": ["TALC", "DTC", "TdgClinicalTrial", "TEND", "MyCancerGenomeClinicalTrial", "PharmGKB"], "pmids": [16133532, 16729906, 17296815, 16474853, 16757355, 28362716], "score": 0.11}, {"interactionId": "b0221984-c43a-4244-9c72-9ae35ade39ac", "interactionTypes": ["inhibitor"], "drugName": "JNJ-26483327", "drugConceptId": "chembl:CHEMBL3545133", "sources": ["ChemblInteractions", "TTD"], "pmids": [], "score": 0.17}, {"interactionId": "2a6c11c0-961c-40e2-98c1-54166f2ed80a", "interactionTypes": ["inhibitor"], "drugName": "NINTEDANIB ESYLATE", "drugConceptId": "chembl:CHEMBL3039504", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.08}, {"interactionId": "69aaa379-c9ae-40dd-b2aa-151ef1f5c260", "interactionTypes": ["inhibitor"], "drugName": "ANLOTINIB", "drugConceptId": "chembl:CHEMBL3545021", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.15}, {"interactionId": "2996be55-61ff-4148-9ce7-a7d390d8807d", "interactionTypes": ["inhibitor"], "drugName": "DOVITINIB", "drugConceptId": "chembl:CHEMBL522892", "sources": ["DTC", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.03}, {"interactionId": "ce94740a-1cfc-4b0f-85ea-a5e4f40176a8", "interactionTypes": ["inhibitor"], "drugName": "LINIFANIB", "drugConceptId": "chembl:CHEMBL223360", "sources": ["DTC", "MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions", "TTD"], "pmids": [], "score": 0.05}, {"interactionId": "91185eb6-80a5-4e6d-a334-485819fc00a7", "interactionTypes": [], "drugName": "PEGPLERANIB SODIUM", "drugConceptId": "chembl:CHEMBL3301576", "sources": ["TdgClinicalTrial"], "pmids": [], "score": 0.12}, {"interactionId": "341cb7f3-6e54-438a-a3d0-cd8f3a4caad4", "interactionTypes": [], "drugName": "AZD-1152-HQPA", "drugConceptId": "chembl:CHEMBL215152", "sources": ["DTC"], "pmids": [], "score": 0.03}]}], "unmatchedTerms": []}